In the US, Darifenacin (darifenacin systemic) is a member of the drug class urinary antispasmodics and is used to treat Overactive Bladder and Urinary Incontinence.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Antispasmodic agent

Muscarinic receptor antagonist (anticholinergic, parasympatholytic agent)


Chemical Names

(S)-1-[2-(2,3-dihydro-5-benzofuranyl)ethyl]-α,α-diphenyl-3-pyrrolidineacetamide (WHO)

(S)-1-[2-(2,3-Dihydrobenzofuran-5-yl)ethyl]-Õ,α-diphenylpyrrolidin-3-acetamid (IUPAC)

(S)-2-{1-[2-(2,3-Dihydrobenzo[b]furan-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide (BAN)

Foreign Names

  • Darifenacinum (Latin)
  • Darifenacin (German)
  • Darifénacine (French)
  • Darifenacina (Spanish)

Generic Names

  • Darifenacin (OS: BAN, USAN)
  • Dasifenacin (IS)
  • UK 88525 (IS: Pfizer)
  • Darifenacin Hydrobromide (OS: BANM, USAN)
  • UK 88525-04 (IS: Pfizer)

Brand Names

  • Emselex
    Novartis, Norway; Novartis, Portugal; Novartis Europharm, Poland
  • Enablex
    Bayer Schering, South Africa
  • Xelena
    Dr. Reddy's, India
  • Continex
    Baliarda, Argentina
  • Darisec
    Elea, Argentina
  • Emselex
    Bayer Vital, Germany; Novartis, Belgium; Novartis, Switzerland; Novartis, Czech Republic; Novartis, Denmark; Novartis, Finland; Novartis, United Kingdom; Novartis, Croatia (Hrvatska); Novartis, Hungary; Novartis, Lithuania; Novartis, Netherlands; Novartis, Serbia; Novartis, Sweden; Novartis, Slovenia; Novartis, Slovakia; Novartis, Turkey; Novartis Europharm Limited, Latvia
  • Enablex
    Bago, Argentina; Novartis, Australia; Novartis, Canada; Novartis Healthcare, Philippines; Warner Chilcott, United States
  • Esmelex
    Novartis, Greece

International Drug Name Search


BANBritish Approved Name
BANMBritish Approved Name (Modified)
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.